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ABSTRACT 
Aqueous decoction of Guiera senegalensis leaves was studied orally and intraperitoneally for its antitrypanosomal activity on mice infected 
experimentally with Trypanosoma brucei brucei. After a phytochemical screening followed by an acute toxicity study on mice, the extract of 
plant was administered once daily for 2 days at doses of 60, 120 and 240 mg / kg orally and 15, 30 and 60 mg / kg intraperito neally after 
infection. Then, parameters of parasitaemia, packed cell volume (PCV), mean survival time and body weight of the mice treated with the extract 
were measured and compared with positive (diminazene aceturate) and negative (distilled water) controls for 7 days in a row. Results indicate 
that the aqueous extract of G. senegalensis leaves contains tannins, flavonoids, saponosides, reducing compounds and anthocyanosides, 
alkaloids and coumarins. LD50 of the extract are 1264.49 mg / kg by oral route and 316.22 mg / kg by intraperitoneal route. The doses of 240 
mg / kg by oral route and 15 and 60 mg / kg by intraperitoneal route of aqueous extract showed a mean survival time (5 days) comparable to 
the positive control. Parasitaemia level increased in all mice tested except in mice treated with diminazene aceturate during the post-infestation 
period. During this period, PCV and body weight of all mice decreased by both routes of administration. These results of the study show the 
pharmacological utility of G. senegalensis leaves in the control of TAA by herders / pastoralists and suggest continuing further bio-guided 
studies to isolate the active components of the plant in order to improve their efficiency.  
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Parasitic diseases such as African Animal Trypanosomoses 
(AAT) are one of the impediments to livestock development 
in sub-Saharan Africa 1. The fight against TAA includes 
several strategies including vector control, the use of 
trypanocidal molecules and the development of vaccines. 
Vector control with continental programs such as PATTEC 
(Pan African Tsetse and Trypanosomosis Eradication 
Campaign) which, in addition to being expensive and 
laborious, has absolutely not allowed to eradicate tsetse flies 
like originally planned 2, 3. The use of trypanocidal molecules 
for prophylaxis (isometamidium chloride) or curative 
(diminazene aceturate) unfortunately has many cases of 
trypanosome resistance in more than 18 African countries 4, 
5, 6. As for the development of vaccines, this strategy is 
uncertain in the near future 7, 8. In the light of these findings, 
new researches on the study of the trypanocidal activity of 
certain medicinal plants commonly used by 
herders/pastoralists are increasingly being explored 9. 
In Burkina Faso, rural population often uses ancestral 
knowledge of medicinal plants to treat diseases of humans 
and animals 10, 11. Recent studies conducted in the country's 
Gaongho Pastoral Zone have shown that farmers extensively 
use plants to treat animal diseases such as AAT 12. 
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Among these plant species, Guiera senegalensis leaves are 
commonly used and its trypanocidal efficacy in vitro on 
Trypanosoma brucei brucei has been proven in a previous 
study 13. Also, the present study was performed to evaluate 
the anti-trypanosomal activity in vivo of G. senegalensis 
leaves according to the procedure of the herders against T. b. 
brucei infected mice.  
MATERIAL AND METHODS 
Plant material and preparation 
The leaves of the G. senegalensis plant were collected in the 
pastoral area of Gaongho. The specimen of the plant was 
identified (Voucher specimen number 5952) at the 
herbarium of “Centre National de la Recherche Scientifique 
et Technologique” in Burkina Faso. 
The leaves of the plant were dried and powdered to prepare 
a decoction aqueous extract in accordance with the herders’ 
procedure 13. Briefly, 200 g of the sample of the plant 
material was placed in a 2000 ml beaker equipped with a lid 
in which a volume of 2000 ml of distilled water was added. 
The mixture was homogenized with a glass rod and then 
boiled on a hot plate for 1 hour (mechanical stirring with a 
glass rod was made from time to time). After, the extract was 
warmed and then filtered by pressing on a fine nylon cloth. 
Obtained filtrate was then centrifuged at 2000 rpm for 10 
minutes. The supernatant was collected and concentrated at 
a temperature of 45°C in a ventilated oven. The concentrated 
decoction obtained was transferred to freezer jars for 
freeze-drying in order to carry out phytochemical screening 
and biological tests. 
Experimental animals 
Healthy female NMRI albino mice, weighing 25-30 gm and 
age of 8 weeks, from the “Centre International de Recherche-
Développement sur l’Elevage en zone Subhumide (CIRDES)” 
were used. Animals were kept in polypropylene cages (6 
animals per cage) under the same conditions of temperature 
(25 ° C), relative humidity of 70-80% and 12:12 h dark / 
light cycle with free access to standard  diet and tap  water 
ad libitum. 
Trypanosome parasite 
The strain of T. b. brucei (reference Farako-ba 80 / CRTA / 
01) was provided by the CIRDES where it is stored in 
nitrogen liquid (-180 ° C). This strain was used to conduct 
the test of the extract antitrypanosomal activity on mice. 
Phytochemical Screening 
The extract was subjected to phytochemical screening for 
the presence of active principles using standard screening 
method of Ciulei 14 (1982). 
Biological tests 
(i) Determination of the acute lethal toxicity  
Determination of the acute lethal toxicity of aqueous extract 
was carried out using oral and intraperitoneal routes 
according to the method described by Lorke 15. In the first 
phase of the method, nine mice fasted for 12 hours before 
were randomly divided into three groups of three mice each. 
Mice from each group received 10, 100 and 1000 mg / kg 
body weight of the aqueous extract using syringe gavage for 
oral route and injection for intraperitoneal route. In the 
second phase of the method, doses of 1600, 2900, and 5000 
mg / kg of aqueous decoction were administered to nine 
mice at the rate of three mice per dose and per route. In 
parallel, a fourth group of three mice receiving only distilled 
water was used as a control group in each phase. After 
administration of the extracts, all mice were kept under 
observation to determine the signs of toxicity ie all 
behavioral, neurological or physical changes at each level. 
These signs were recorded at 4 hours and 24 hours after 
treatment of the mice with particular attention on the first 4 
hours. At the end of the 24-hour follow-up, lethal doses 50 
(LD50) were evaluated according to the two routes of 
administration applied. 
(ii) Antitrypanosomal activity Test 
Antitrypanosomal activity test of the aqueous decoction of 
the leaves of G. senegalensis was carried out on mice 
subjected to two routes of administration (oral and 
intraperitoneal). For each route of administration, three 
groups of 6 mice were constituted and submitted to three 
increasing doses. These doses were obtained from the acute 
toxicity test which permitted to determine the lethal dose 50 
(LD50) of aqueous extract according to each applied 
administration route (dose 1: [dose 2] / 2, dose 2: [LD50] / 
10 and dose 3: [LD 50] x 2). In parallel, two other control 
groups of 6 mice each were used for comparisons: negative 
control group (distilled water) and a positive control group 
(Veriben : diminazene aceturate). The mice of the different 
groups were distributed in cages for an adaptation period of 
7 days (day 7: d7) under an average temperature of 25 ° C 
before being infected on the eighth day (day 8: d8) with T. b. 
brucei intraperitoneally. This infection was made with 0.2 
mL of infected mice blood (104 trypanosomes / mL). The 
treatments of the mice were made on the 3rd day post-
infection (day 10: d10) when the parasitaemia peak was 
reached (108 trypanosomes per ml of blood). The treatments 
were applied for two days in a row (day 10 and day 11: d10 
and d11) with the three increasing doses of the extracts. The 
positive control group was treated at one time (day 10: d10) 
according to the manufacturer's procedure and the negative 
control received no treatment. The Antitrypanosomal 
activity of extract was evaluated using parameters such as 
parasitaemia, packed cell volume (PCV), body weight and 
mean survival time of mice. 
Determination of parasitemia 
The parasitemia level for each mouse was performed daily 
(d8 to d15) by microscopic examination of a drop of blood 
obtained from the tail tip in triplicates 16. The fresh blood 
was placed between slide and coverslip and observed under 
a microscope at 400X. 
Determination of PCV 
PCV was measured every two days (d7, d9, d11, d13 and d15) to 
indirectly determine the degree of anemia of the mice 
treated with aqueous extract compared to the control 
groups. For this, the blood was collected from the tail of each 
mouse in heparinized capillary tubes which were subjected 
to centrifugation at 12500 rpm for 5 minutes for a good 
separation of the constituents. The PCV reading was made 
using a haematocrit reader expressed in percentage. 
Body weight  
Body weight of each mouse per group was recorded daily 
from d7 to d15. For this, the mice were weighed individually.  
 Mean survival time 
This parameter was calculated for each mouse in the treated 
with plant extract and controls groups throughout the 
follow-up period by differentiating between the day the 
mouse dies and the day of treatment. 
Statistical analysis 
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For the calculation of the LD50, the formula was applied : 
LD50 =√(D0×D100) where D0  is the highest dose that causes 
no mortality and D100 is the lowest dose that produces 100% 
mortality 15. The results of the phytochemical screening 
were noted - (absence) or + (presence). For 
antitrypanosomal activity test, data obtained were 
expressed as mean ± standard deviation of mean of 
measured parameters and subjected to one-way analysis 
followed by Tukey’s test at 5% for comparison of the results 
obtained from diﬀerent groups. 
 
RESULTS 
Determination of the LD50 
The results of the acute toxicity study of extract are 
presented in Table 1. The intraperitoneal route presented 
mice mortality at the dose of 1000 mg / kg in phase 1. In 
contrast, the oral route induced mortality of the mice at the 
dose of 1600 mg / kg PC in phase 2. According to formula of 
Lorke 15 (1983), the lethal doses 50 (LD 50) of the extract 
tested are 1264.49 mg / kg by oral route and 316.22 mg / kg 
by intraperitoneal route.  
 
Table 1: Acute toxicity effect of G. senegalensis leaves aqueous extract administrated orally and intraperitoneal route in mice. 
Phases Doses (mg/kg) Number of 
mice used 
Mortality number 
Orally route Intraperitoneal 
route 
Phase 1 10 03 00 00 
100 03 00 00 
1 000 03 00 03 
Control Distilled water 03 00 00 
Phase 2 1 600 03 03 03 
2 900 03 03 03 
5 000 03 03 03 
 
Phytochemical Screening 
The phytochemical profile of the extract revealed the 
presence of phenolic compounds (tannins), saponosides, 
alkaloids, anthocyanosides, reducing compounds, steroid 
glycosides, triterpenes, carbohydrates, flavone glycosides 
and coumarins (Table 2). 
Table 2: Phytochemical profile of the aqueous decoction of 
G. senegalensis 
Chemical groups decoction of G. 
senegalensis 
Polyphenols (tannins)  ++ 
saponosides  ++ 
Alkaloids salts  ++ 
Reducing compounds  ++ 
carbohydrates  + 
anthocyanosides  ++ 
Steroid glycosides  ++ 
Triterpene glycosides ++ 
Flavone Glycosides  + 
Anthracénosides  nd 
Cardiac glycosides  nd 
Coumarines and derivatives  + 
++ = abundant; + = not abundant; nd = not detected 
 
 
In vivo test 
(i) Mean survival time 
Figure 1 show the mean survival time of mice in all groups 
after the application of treatments compared to the control 
groups. The mean survival time of the negative control 
group (distilled water) was one day after the application of 
the treatment. In contrast, there was an increase in the mean 
survival time (5 days) of mice in the groups treated with the 
plant extract at the doses of 240 mg / kg orally and 15 and 
60 mg / kg intraperitoneally and  the positive control group 
(Veriben : Diminazene aceturate). 
 
Figure 1: Mean survival time of mice after the treatment 
application in all groups during the study (GS: G. senegalensis 
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(ii) Parasitemia Level 
Parasitemia levels (in log number / mL) in all groups of mice 
are presented in Figure 2. The mice were parasitized as early 
as the second day after infection (d9) and all died at d11 in the 
negative control group (distilled water). The mice were 
parasitized as early as the second day after infection (d9) and 
all died on d11 in the negative control group. The number of 
trypanosomes in the blood of mice in all study groups 
increased over time except in the positive control group 
where trypanosomes died on the second day of diminazene 
aceturate administration (d11). The degree of parasitaemia 
between the groups treated with the extract at a dose of 240 
mg / kg orally and those treated with the doses of 15 mg / kg 
and 60 mg / kg intraperitoneally was not significantly 
different (p ˃ 0.05) during the post-treatment period. 
 
 
Figure 2: Parasitaemia levels of mice after the treatment application in all groups during the study (GS: G. senegalensis ; vo : 
oral route ; ip : intraperitoneal route) . 
 
(iii) Packed cell volume 
Figure 3 shows the PCV levels of mice in the tested groups. 
PCV means after the infection of mice decreased from d7 to 
d15 in all groups. These PCV means of mice group treated 
with diminazene aceturate were higher (p˂0.05) than those 
of the mice treated with extract at the doses of 240 mg / kg 




Figure 3: PCV levels of mice after the treatment application in all groups during the study (GS: G. senegalensis ; vo : oral route ; 
ip : intraperitoneal route). 
(iv) Body weight change 
Body weight change of mice at d7 to d15 of experiment is 
reported in Figure 4. After infection with T. b. brucei, a 
significant weight decrease (p˂0.05) from d8 to d15 in 
experimental mice was observed in all groups. This weight 
loss was more marked (p˂0.05) in the treated groups with 
oral doses of 240 mg / kg (10.08%) and 60 mg / kg (7.61%) 
by the oral route. intraperitoneal compared with the groups 
treated with diminazene aceturate (4.68%) and 15 mg 
(4.93%) intraperitoneally. With mice treated with 
diminazene aceturate, the weight loss was followed by a 
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Figure 4: Body weights of mice in mice after the treatment application in all groups during the study (GS: G. senegalensis ; vo : 
oral route ; ip : intraperitoneal route) 
DISCUSSION 
In this study, the efficacy of aqueous decoction of G. 
senegalensis leaves as trypanocidal in mice experimentally 
infected with a T. brucei brucei strain was tested. This 
approach aims to explore veterinary ethnomedicine 
practiced by farmers in rural areas of Africa in the 
treatment of animal diseases 17. To improve these 
practices, the study of the toxicity of natural drugs used is 
very important to determine their safety. 
The acute toxicity results of aqueous decoction of G. 
senegalensis leaves in mice have a dose-response effect 
depending on the administration routes. The LD50 of the 
extract was 1264.49 mg / kg orally and 316.22 mg / kg 
intraperitoneally. This difference of the LD50 between the 
two routes of administration corroborates the 
observations made by Lahlou et al. 18 and Amein et al. 19 
with the aqueous extract of Tanacetum vulgare and 
thymoquinone in mice. The LD50 analysis obtained in our 
study revealed that the aqueous leaf extract of G. 
senegalensis is slightly toxic by oral route and moderately 
toxic by intraperitoneal (IP) route according to the toxicity 
scale of Hodge and Sterner 20. 
Similar results were obtained with the hydro-methanolic 
root extract of G. senegalensis and the infusion of Cassia 
sieberiana root bark orally by Shettima et al. 21 and Ajayi et 
al.22 respectively. By intraperitoneal route, the results 
obtained in our study are comparable to those of Fané 23 
with the aqueous macerate of C. sieberiana root bark in 
mice, although the two methods of preparation are 
different. The low toxicity of G. senegalensis extract orally 
in mice confirms its usual use by herders/pastoralists and 
traditional healers in the treatment of various human and 
animal diseases, including TAA 12. 
Phytochemical screening of the leaf extract of G. 
senegalensis revealed several chemical groups with 
recognized pharmacological activities. These groups are 
tannins, saponosides, reducing compounds, carbohydrates, 
anthocyanosides, steroid glycosides, triterpenes, alkaloid 
salts and coumarins and derivatives. These results are in 
agreement with those of Kouamé et al. 24 and Yagana et al. 
25 who found tannins, saponosides, carbohydrates, 
terpenoids, flavonoids and alkaloids in the G. senegalensis 
leaves. Similarly, the presence of coumarins and 
derivatives obtained in our study confirms the 
observations of Soulama et al. 26 who report that natural 
coumarins are secondary metabolites synthesized by plant 
leaves. All these chemical groups contained in the extract 
would have the power to act on one or more target sites 
associated with a physiological process 27 and to interfere 
with the redox balance of parasites acting on the 
respiratory chain or cellular defenses against oxidative 
stress that partially eliminate trypanosomes 27, 28. 
Indeed, flavonoids inhibit the growth of trypanosomes and 
act on trypomastigote forms found in the bloodstream of 
mammals 29, 30. Similarly, flavonoids from natural plants act 
as free radicals and metal chelators that inhibit lipid 
peroxidation and exhibit various physiological activities, 
including antihypertensives and anti-arthritic activities 31. 
Alkaloids reduce the growth of trypanosomes by 
intercalating deoxyribonucleic acid (DNA) with 
trypanosomes 32 and inhibiting protein synthesis 29. The 
anti-trypanosome activity of the phenolic compounds is 
the inhibition of the alternative trypanosome oxidase 
enzyme 33. According to Taylor et al. 34 one of the 
molecular actions of tannins is to complex proteins 
through so-called non-specific forces such as hydrogen 
bonding, the hydrophobic effect as well as the covalent 
bond formation. For terpenes, the mechanisms of 
trypanocidal activity include the formation of aldehyde-
thiol adducts with sulfur-containing components, thereby 
decreasing the buffering of agents that can create oxidative 
stress in the cells 35 and the oxidation of glutathione and 
pyruvic acids 36.  
After infection of the mice on day 8, a high parasitemia 
(108 trypanosomes per ml of blood) was observed in all the 
groups on day 10 followed by mouse mortality between 2 
and 7 days. The pre-patent period (2-7 days) of T. b. brucei 
in the study is different from that (7-11 days) obtained by 
Bengaly et al. 37 on mice infected with Trypanosoma 
congolense at a dose of 105 trypanosomes/mL of blood. The 
duration of the pre-patent period could then be thought to 
depend on the parasite strain and the immune status of the 
infected host, although T. congolense generally has a longer 
pre-patent period than T. brucei. Nevertheless, the survival 
time of the mice in the study is close to that (5 to 7 days) of 
Kelly et al. 38 who infected CDI strain mice with T. b. brucei 
at the dose of 105 trypanosomes (strain 427). 
Intraperitoneally, an average survival time of 5 days was 
observed with two doses (15 and 60 mg / kg) of the extract 
tested whereas this survival time was only reached with 
the dose of 240 mg / Kg orally. This shows a clear 
efficiency of the intraperitoneal route compared to the oral 
route. These results are in phase with those obtained by 
Benoit-Vical et al. 39 evaluating Chrozophora senegalensis in 
the treatment of malaria on mice. According to these 
authors, this difference could be due to the low 
bioavailability of the extract administered orally. In fact, 
the average survival times of the mice infected and treated 
with the doses of 240 mg / kg oral and those of 15 and 60 
mg / kg by intraperitoneal route could be attributed to the 
activity of the chemical components that the extract 
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reveal that polyphenols have the ability to increase the 
survival of mice infected with T. b. brucei 40, 41. Similarly, 
Mergia et al. 34 revealed that administration of the 
methanolic extract of Clutia abyssinica resulted in a 
survival time of 39.20 ± 0.37 days in mice infected with 
Trypanosoma congolense. The survival time of the mice 
despite increasing parasitemia over time in the study 
suggests that administration of the extract does not 
completely eliminate trypanosomes from the blood of 
infected mice during the study. Several works  42, 43, 44 have 
led to similar observations and concluded that a high 
parasite load could mask the effectiveness of the crude 
extracts of the plant 45. This could be due to the enzymatic 
inactivation of the phytochemicals that these extracts 
contain 46. On the other hand, the pharmacokinetics of the 
phytochemicals of the tested extract, including their rapid 
elimination, may also explain the low in vivo efficacy of the 
decoction 47. These hypotheses reinforce the observations 
made because the trypanocidal efficacy in vitro of the 
aqueous extract of the plant has been proved previously on 
T. b. brucei with increasing doses of 25, 50 and 100 mg / ml 
by Zongo et al. 13. Similar finding is made by Abedo et al. 48 
evaluating the trypanosomal activity of methanolic extract 
of stem bark Gongorenema latifolium on mice infected with 
Trypanosoma congolense in Nigeria. 
After infection of the mice, the PCV level decreased 
continuously. This could be explained by hemolysis of red 
blood cells associated with increased parasitemia. Indeed, 
trypanosome infections cause an increase in the sensitivity 
of the red blood cell membrane to oxidative damage. 
Oxygen-generated oxygen reactions released by 
trypanosomes can also damage red cell membranes and 
cause haemolysis 49. The effect of the extract in anemia 
would be to reduce parasite load while neutralizing the 
toxic metabolites produced by trypanosomes or by 
trapping free radicals associated with trypanosomes that 
could be attributed to the secondary metabolites 
mentioned above 45, 50, 41. 
Our results also showed a decrease in mouse weights since 
their infection with T. b. brucei. This is fully in line with the 
findings of Alli et al. 41 (2011) who showed that T. b. brucei 
was associated with weight loss. This decrease in body 
weight could also be explained by the drop in the PCV level 
associated with a high parasitemia level followed by a 
decrease in appetite. This results in consumption of fat 
stores and severe degenerative changes in muscle cells and 
other tissues in the infested host. In addition, there is 
increased degradation of proteins in the muscles leading to 
atrophic degeneration. Decreased supply of oxygen can 
cause anemia and this is also an important factor 51, 52. 
CONCLUSION 
The results of this study showed that the decoction of G. 
senegalensis leaves leads to an average survival time of the 
treated mice comparable to those of the positive control 
group although they are parasitized. This is probably 
related to the metabolite substances that the extract 
contains. Therefore, leaves of G. senegalensis could be 
considered as a potential source for the search for new 
drugs against TAA. For this purpose, additional studies 
could be conducted to isolate the active components of the 
extract to improve the plant anti-trypanosomal activity. 
ACKNOWLEDGMENTS 
The authors are grateful to the project FCN 05-2014 of 
PPAAO/WAAPP of Burkina Faso for financial support 
provided. 
CONFLICT OF INTEREST 
There is no conflict of interest among the authors. 
REFERENCES  
1. Sow A., Sidibe I., Bengaly Z., Bance A.Z., Sawadogo G.J. (2012). 
Irradiated Male Tsetse from a 40-Year-Old Colony Are Still 
Competitive in a Riparian Forest in Burkina Faso. PLoS ONE. 
7(5).  
2. Bouyer J., Seck MT., Sall B. (2013). Misleading guidance for 
decision making on tsetse eradication: Response to Shaw et al. 
(2013). Prev. Vet. Med. 
http://dx.doi.org/10.1016/j.prevetmed.2013.05.017. 
3. Shaw A.P., Torr S.J., Waiswa C., Cecchi G., Wint G.R., Mattioli R.C., 
Robinson T.P. (2013). Reply to the letter to the editor by 
Bouyer et al.. Prev. Vet. Med. 112, 447-449. 
4. Delespaux V., Dinka H., Masumu, J., Van den Bossche P., Geerts S. 
(2008a). Five fold increase in the proportion of diminazene 
aceturate resistant Trypanosoma congolense isolates over a 
seven years period in Eastern Zambia. Drug Resist Update 11, 
205-209. 
5. Vitouley HS., Bengaly Z., Adakal H., Sidibe I., Van Den Abbeele, J., 
Delespaux, V. (2013). Réseau d'EpidémioSurveillance de la 
Chimiorésistance aux trypanocides et aux acaricides en 
Afrique de l'Ouest (RESCAO). Tropicultura. 31, 205-212. 
6. Tchamdja E., Kulo A. E., Vitouley H. S., Batawui K., Bankole A. A., 
Adomefa K., Cecchi G., Hoppenheit A., Clausen P. H., De Deken 
R., Van Den Abbeele J., Marcotty T., Delespaux V. (2017). Cattle 
breeding, trypanosomosis prevalence and drug resistance in 
Northern Togo. Veterinary 
Parasitology.http://dx.doi.org/10.1016/j.vetpar.2017.02.008 
7. Magez S., Radwanska M. (2009). African trypanosomiasis and 
antibodies: implications for vaccination, therapy and 
diagnosis. Future Microbiology 4, 1075-1087. 
8. Magez S., Caljon G., Tran T., Stijlemans B., Radwanska M. (2010). 
Current status of vaccination against African trypanosomiasis. 
Parasitology 137, 2017-2027. 
9. Vitouley HS., Bengaly Z., Lapo RA., Gbati, OB., Assane M. (2007). 
Etude du potentiel trypanocide d'extraits aqueux de plantes 
médinales pour le traitement de la trypanosomose animale 
africaine. Revue Africaine de Santé et de Productions 
Animales. 5, 9-15. 
10. Ouedraogo S., Belemnaba L., Traore A., Lompo M., Bucher 
B.Guissou I.P. (2008). Etude de la toxicite et des proprietes 
pharmacologiques de l’extrait aqueux de anogeissus leiocarpus 
(dc) guill. et perr (combretaceae). Pharmacopée et médecine 
traditionnelle africaines. 15 : 18 – 22 
11. Centre for Analysis of Economic and Social Policy (CAPES) 
(2006). Inventory of local knowledge in Burkina Faso. 
Inventory of good practices and proposals for their 
contribution to development. Ouagadougou. 448 pages. 
12. Zongo A., Kaboré A., Traoré A., Zabré G., Traoré A., Tamboura 
H. H., Belem A. M. G. (2017a). Constraints of Ruminant Rearing 
and Ethno-veterinary Practice Against African Animal 
Trypanosomosis in the Pastoral Area of Gaongho in Burkina 
Faso. Animal and Veterinary Sciences. 5(1): 1-7. Doi: 
10.11648/j.avs.20170501.11. 
13. Zongo A., Kaboré A., Bengaly Z., Vitouley H.S., Traoré A., 
Tambora H.H., Belem.A.M.G. (2017b). Prevalence of 
trypanosoma brucei brucei and potential in vitro trypanocidal 
activity of aqueous extracts of some medicinal plants in the 
pastoral area of gaongho in Burkina Faso. J. Anim. Health Prod. 
5(3): 107-114. 
14. Ciulei I. (1982). Methodology for analysis of vegetable drug. 
Practical manual on industrial utilization of medicinal and 
aromatic plants, Bucharest, Ministry of Chemical industry, 67 
pages. 
15 Lorke D. (1983). A new approach to practical acute toxicity 
testing. Arch. Toxicol. 54: 275-287. 
16. Herbert WJ, Lumsden WHR (1976). Trypanosoma brucei: A 
rapid “matching”method for estimating the host’s parasitemia. 
Experiment. Parasitol. 40: 427-431. 
17. Bâ A. S. (1996). Passé, présent et perspectives de l'ethno-
médecine vétérinaire africaine. Rev. sci. tech. Off. int. Epiz. 15 
(3), 813-826. 
18. Lahlou S., Israili Z., Lyoussi B. (2008). Acute and chronic 
toxicity of a lyophilized aqueous extract of Tanacetum vulgare 
leaves in rodents. J. Ethnopharmacol. 117: 221-227. 
André et al                                                                                            Journal of Drug Delivery & Therapeutics. 2019; 9(4-s):273-279 
ISSN: 2250-1177                                                                                  [279]                                                                                 CODEN (USA): JDDTAO 
19. Amein A., Alkhawajah A.,A., Randhawa M. A., Sheikh N.A. 
(2008). Oral and intraperitonéale LD50 of thymoquinone, an 
active principle of Nigella sativa in mice and rats. J. Ayub. Med. 
Coll. Abbottabad., 20(2): 25-27. 
20. Hodge HC., Sterner JH. (1943). Determination of substances 
acute toxicity by LDB50B. Amer. Industrial Hyg. Assoc. 10: 93. 
21. Shettima Y.A., Tijjani M.A., Karumi Y., Sodipo O. A. (2012). 
Phytochemical and anti-diarrhoeal properties of methanol 
root extract of Guiera senegalensis J.F.Gmel. Inter. Tes. J. 
Pharmacy, 3 (11): 61- 65. 
22. Ajayi C. O., Elujoba A. A., Bejide R. A., Akinloye J. A., Omonisi A. 
E. (2015). Toxicity and Pharmacognostic Standards for 
Laxative Properties of Nigerian Cassia sieberiana and Senna 
obtusifolia Roots. European Journal of Medicinal Plants. 6(2): 
110-123. 
23. Fané S., (2003). Etude de la toxicité de certaines plantes 
vendues sur les marchés du district de Bamako. Thèse de 
Pharmacie. Université de Bamako, Mali, 153 pages. 
24. Kouamé J., Gnoula C., Palé E., Bassolé H., Guissou IP., Simporé J., 
Nikiéma JB. (2009). Etude des propriétés cytotoxiques et anti-
radicalaires d’extraits de feuilles et de galles de Guiera 
senegalensis J. F. Gmel (Combretacae). Science et technique, 
Sciences de la santé. 32 (1-2): 9-23. 
25. Yagana S., A., Sodipo O. A., Yagana K., Modu S. (2012). 
Antibacterial activities of the extracts of the roots of Guiera 
senagalensis J.F.Gmel. J. Pharm. BioMed Sci., 23: 1-7. 
26. Soulama S., Nacoulma O. G., Meda R. N., Boussim J. I., Millogo-
Rasolodimby J. (2013). Teneurs en coumarines de 15 ligneux 
fourragers du Burkina Faso. Int. J. Biol. Chem. Sci. 7(6): 2283-
2291. 
27. Maikai V. A. (2011). Antitrypanosomal activity of flavonoid 
extracted from Ximenia Americana stem bark. Int J. Biol. 
3(1):115-121. 
28. Wurochekke AU., Anyanwu GO., (2012). Antitrypanosomal 
activity of Anogeissus leiocarpus in rats infected with 
Trypanosoma brucei brucei . Int. Res. J. Biotechnol. 3(1):5-9. 
29. Camacho MD. Mata R., Castaneda P., Kirby GC., Warhurst DC., 
Croft SL., Phillipson JD. (2000). Bioactive compounds from 
Celaenodendron mexicanum. Planta Med. 66, 463-468. 
30. Grecco SS., Reimão JQ., Tempone AG., Sartorelli P., Romoff P., 
Ferreira  MJP., Fávero OA., Lago JHG. (2010). Isolation of an 
antileishmanial and antitrypanosomal flavanone from the 
leaves of Baccharis retusa DC. (Asteraceae). Parasitol. Res. 
106, 1245–1248. 
31. Hoet S., Opperdoes F., Brun R., Quetin-Leclercq J. (2004). 
Natural products active against African trypanosomes: a step 
towards new drugs. Nat Prod Rep 21: 353-364. 
32. Atawodi S., E., Bulus T., Ibrahim S., Ameh D. A., Nok A. J., 
Mamman M., Galadima M. (2003). In vitro trypanocidal effect 
of methanolic extract of some Nigerian Savannah plants. 
African Journal of Biotechnology. 2 (9), pp. 317-321  
33. Yabu Y., Yoshida A., Suzuki T., Nihei C., Kawai K. (2003). The 
efficacy of ascofuranone in a consecutive treatment on 
Trypanosoma brucei brucei in mice. Parasitol Int, 52: 155-164. 
34. Mergia E., Shibeshi W., Terefe G., Teklehaymanot T. (2014). 
Evaluation of In vivo Antitrypanosomal Activity of Aqueous 
and Methanol Leaf Extracts of Clutia abyssinica 
(Euphorbiaceae) against Trypanosoma congolense Field 
Isolate. Nat. Prod. Chem. Res. 2:138. 
35. Nibret E., Wink M. (2010) Volatile components of four 
Ethiopian Artemisia species extracts and their in vitro 
antitrypanosomal and cytotoxic activities. Phytomedicine. 17: 
369-374. 
36. Saeidnia S., Gohari A.R., Uchiyama N., Ito M., Honda G. (2004). 
Two new monoterpene glycosides and trypanocidal 
terpenoids from Dracocephalum kotschyi. Chem. Pharm. Bull. 
52: 1249-1250. 
37. Bengaly Z., Ganaba R., Sidibe I., Sawadogo L., (2002). 
Comparative pathogenicity of three genetically distinct types 
of Trypanosoma congolense in cattle: Clinical observations and 
haematological changes. Veterinary Parasitology. 108(1):1-19. 
38. Kelly JM., Quack G., Miles MM. (2001). In Vitro and In Vivo 
Activities of Aminoadamantane and Aminoalkylcyclohexane 
Derivatives against Trypanosoma brucei. Antimicrobial Agents 
Chemotherapy. 45 (5):1360-1366  
39. Benoit-Vical F., Soh Njommang P., Saléry M., Harguem L., 
Poupat C., Nongonierma R., (2008). Evaluation of Senegalese 
plants used in malaria treatment: Focus on Chrozophora 
senegalensis. Journal of Ethnopharmacology. 116:43–48 
40. Ngure RM., Ongeri B., Karori S.M., Wachira W., Maathai RG., 
Kibugi JK., Wachira, FN. (2009). Antitrypanosomal effects of 
Azadirachta indica (neem) extract on Trypanosoma brucei 
rhodesiens -infected mice. Engl. J. Med. 14: 2-9.  
41. Alli L. A., Okochi V. I., Adesoken A.A. (2011). Antitrypanosomal 
activity and hematological effects of aqueous extract of leaves 
of Morinda Lucida on Trypanosoma brucei brucei infected rats. 
Asian J pharm hea Sci 1: 111-115. 
42. Wurochekke A.U., Nok A.J. (2004). In vitro and in vivo 
antitrypanosomal activity of the leaf of Lawsonia inermis 
against Trypanosoma brucei brucei infection in mice. J Medical 
Sci. 4: 236-239. 
43. Ibrahim H., Ogbadoyi E., Adamu K., Bello M., Yemisi I. (2012). 
Evaluation of antitrypanosomal activity of ethyl acetate 
extract of Adansonia digitata seed extract in T. b. brucei 
infected albino mice. Int J Drug Res Tech, 2: 454-460. 
44. Ogbadoyi E., Adamu Y., Omotosho R. (2011) Preliminary 
studies of the antitrypanosomal activity of Garcinia kola nut 
extract in mice infected with T. b. brucei. Journal of Medicine 
and Medical Sciences. 2: 628-631. 
45. Ekanem JT., Kolawole OM., Abbah OC. (2008). Some 
biochemical and haematological effects of black seed (Nigella 
sativa) oil on Trypanosoma brucei infected rats. Afr J Biochem 
Res 2: 79-85. 
46. Mann A., Egwim EC., Banji B., Abdukadir N., Gbate M. (2009). 
Efficacy of Dissotis rotundifolia on Trypanosoma brucei brucei 
infection in rats. Afr. J. Biochem. Res. 3: 5-8. 
47. Williams S., Saha L., Singha U.K., Chaudhuri M. (2008). 
Trypanosoma brucei: differential requirement of membrane 
potential for import of proteins into mitochondria in two 
developmental stages. Exp Parasitol. 118: 420-433. 
48. Abedo J. A., Jonah O. A., Abdullahi R. S., Mazadu M. R., Idris H. Y., 
Muhammed H., Shettima F. T., Ombugadu S., Daudu M., Garba 
J., Abdulmalik U., Kugu B. A., Usman A. O., (2013). Evaluation 
of trypanosomal activity of Tapinanthus globiferus and 
Gongronema latifolium on Trypanosoma congolense. 
Bioscience Research. 10(1): 20-28. 
49. Albert M., Hussein K. (2012). The Mechanisms of anemia in 
trypanosomiasis: A Review, Anemia, Dr. Donald Silverberg 
(Edition). 
50. Inabo H.I., Fathuddin MM. (2011). In vivo antitrypanosomal 
potentials of ethyl acetate leaf extracts of Punica granatum 
against T. b. brucei. Advances in Agricultural biotechnology. 1: 
82-86. 
51. Holmes P.H., Katunguka-Rwakishaya E., Bennison J.J., Wassink 
G.J., Parkins J.J. (2000). Impact of nutrition on the 
pathophysiology of bovine trypanosomiasis. Parasitology. 
120: 73-85. 
52. Tatli Z. A. (2004). Chemical Constituents of Verbascum L. 
Species FABAD. J. Pharm. Sci. 29: 93-107. 
 
 
